D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,551,019
- Value
- $101.1M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,551,019 | $101.1M | 0.1% | −1,020,578−8.1% | Reduced | Holders |
| Q1 2026 | 12,571,597 | $96.4M | 0.1% | +12,571,597 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −237,147−100.0% | Sold out | Holders |
| Q2 2025 | 237,147 | $626.1K | <0.1% | +237,147 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −520,053−100.0% | Sold out | Holders |
| Q3 2024 | 520,053 | $1.93M | <0.1% | +520,053 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −236,634−100.0% | Sold out | Holders |
| Q1 2024 | 236,634 | $1.27M | <0.1% | −354,467−60.0% | Reduced | Holders |
| Q4 2023 | 591,101 | $2.97M | <0.1% | +591,101 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −678,504−100.0% | Sold out | Holders |
| Q3 2022 | 678,504 | $3.37M | <0.1% | +267,827+65.2% | Added | Holders |
| Q2 2022 | 410,677 | $1.53M | <0.1% | +315,409+331.1% | Added | Holders |
| Q1 2022 | 95,268 | $534.0K | <0.1% | −235,233−71.2% | Reduced | Holders |
| Q4 2021 | 330,501 | $2.01M | <0.1% | −46,969−12.4% | Reduced | Holders |
| Q3 2021 | 377,470 | $3.68M | <0.1% | +293,098+347.4% | Added | Holders |
| Q2 2021 | 84,372 | $1.21M | <0.1% | +84,372 | New | Holders |